atai Life Sciences (ATAI)
(Delayed Data from NSDQ)
$4.17 USD
+0.07 (1.71%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $4.18 +0.01 (0.24%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, atai Life Sciences N.V. has a market cap of $821.38M, which represents its share price of $4.10 multiplied by its outstanding shares number of 200.34M. As a small-cap company, ATAI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ATAI 4.17 +0.07(1.71%)
Will ATAI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATAI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATAI
atai Life Sciences (ATAI) Upgraded to Strong Buy: Here's Why
Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?
ATAI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year?
Are You Looking for a Top Momentum Pick? Why atai Life Sciences N.V. (ATAI) is a Great Choice
Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?
Other News for ATAI
Oppenheimer Boosts Price Target for ATAI Life Sciences Due to Promising Prospects
Atai Life Sciences price target raised by $2 at Oppenheimer, here's why
Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks
Psychedelic: Filament reports compassionate use approval for psilocybin
This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday